We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 1,097 results
  1. The Role of Tau Proteoforms in Health and Disease

    Tau is a microtubule-associated binding protein in the nervous system that is known for its role in stabilizing microtubules throughout the nerve...

    Zuha Waheed, Jawaria Choudhary, ... Saima Zafar in Molecular Neurobiology
    Article 02 June 2023
  2. Differential vulnerability of the dentate gyrus to tauopathies in dementias

    The dentate gyrus (DG), a key hippocampal subregion in memory processing, generally resists phosphorylated tau accumulation in the amnestic dementia...

    Allegra Kawles, Grace Minogue, ... Tamar Gefen in Acta Neuropathologica Communications
    Article Open access 03 January 2023
  3. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance

    Frontotemporal lobar degeneration with TPD-43-immunoreactive pathology (FTLD-TDP) is subclassified based on the type and cortical laminar...
    Manuela Neumann, Edward B. Lee, Ian R. Mackenzie in Frontotemporal Dementias
    Chapter 2021
  4. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies

    Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a...

    Ilaria Linda Dellarole, Elena Vacchi, ... Giorgia Melli in npj Parkinson's Disease
    Article Open access 15 June 2024
  5. Tau Pathology in Neurodegenerative Diseases

    Aggregation and cellular accumulation of tau protein is a defining feature of tauopathies, a class of histopathologically and clinically...
    Thomas Vogels, Tomáš Hromádka in Neurodegenerative Diseases Biomarkers
    Protocol 2022
  6. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

    Despite recent advances in fluid biomarker research in Alzheimer’s disease (AD), there are no fluid biomarkers or imaging tracers with utility for...

    Kanta Horie, Nicolas R. Barthélemy, ... Chihiro Sato in Nature Medicine
    Article Open access 24 November 2022
  7. Clinical and Biochemical Heterogeneity of Parkinson’s Disease

    Objectives. To study the relationship between measures of oxidative stress and clinical changes in patients with neurodegenerative parkinsonism and...

    Kh. I. Khadzieva, I. V. Chernikova, ... A. A. Plotnikov in Neuroscience and Behavioral Physiology
    Article 01 October 2021
  8. Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors

    Movement disorders (MD) have been linked to degeneration of the substantia nigra (SN) in Parkinson’s disease and include bradykinesia, rigidity, and...

    Luigi Fiondella, Priya Gami-Patel, ... Anke A. Dijkstra in Acta Neuropathologica Communications
    Article Open access 12 April 2023
  9. Seed amplification and RT-QuIC assays to investigate protein seed structures and strains

    The accumulation of misfolded proteins as amyloid fibrils in the brain is characteristic of most neurodegenerative disorders. These misfolded...

    Heidi G. Standke, Allison Kraus in Cell and Tissue Research
    Article 08 March 2022
  10. The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis

    Atypical Parkinsonism (AP) syndromes are characterized by a wide spectrum of non-motor symptoms including prominent attentional and executive...

    Simona Raimo, Mariachiara Gaita, ... Gabriella Santangelo in Neuropsychology Review
    Article 12 August 2022
  11. New Approaches to the Treatment of Frontotemporal Dementia

    Frontotemporal dementia (FTD) comprises a diverse group of clinical neurodegenerative syndromes characterized by progressive changes in behavior,...

    Kyra D. Neylan, Bruce L. Miller in Neurotherapeutics
    Article 08 May 2023
  12. Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population

    Background

    Previous studies demonstrated increases in diagnostic confidence and change in patient management after amyloid-PET. However, studies...

    Lyduine E. Collij, Gill Farrar, ... Femke Bouwman in Alzheimer's Research & Therapy
    Article Open access 27 November 2023
  13. Rhombomere 10 r10

    Ascending cranially in the brainstem, this chapter deals with some more precerebellar nuclei—projecting to the cerebellum—like the lateral reticular...
    Hannsjörg Schröder, Rob A. I. de Vos, ... Natasha Moser in The Human Brainstem
    Chapter 2023
  14. Seeding Activity of Skin Misfolded Proteins as a Biomarker in Prion and Prion-Like Diseases

    Prion disease (PrD) and other prion-like diseases, including but not limited to Alzheimer’s disease (AD) and Parkinson’s disease (PD), are...
    Wen-Quan Zou, Zerui Wang in Prions and Diseases
    Chapter 2023
  15. The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration

    Neurodegenerative diseases encompass a heterogeneous group of conditions characterised by the progressive degeneration of the structure and function...

    Katherine Fodder, Rohan de Silva, ... Conceição Bettencourt in Acta Neuropathologica Communications
    Article Open access 29 June 2023
  16. The Spectrum of Tau Pathology in Human Prion Disease

    Intracellular deposition of hyperphosphorylated tau characterizes tauopathies: there is a spectrum from neuron-predominant through mixed neuronal and...
    Gabor G. Kovacs, Herbert Budka in Prions and Diseases
    Chapter 2023
  17. Ballooned neurons in semi-recent severe traumatic brain injury

    Traumatic brain injury (TBI) is now recognized as an insult triggering a dynamic process of degeneration and regeneration potentially evolving for...

    Jean Michaud, Isabelle Plu, ... John Woulfe in Acta Neuropathologica Communications
    Article Open access 10 March 2023
  18. Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes

    Parkinson’s disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) are characterized by nigrostriatal degeneration. We...

    Nils Schröter, Ganna Blazhenets, ... Joachim Brumberg in npj Parkinson's Disease
    Article Open access 29 September 2022
  19. Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease

    Background

    There is a need for biomarkers to support an accurate diagnosis of Parkinson’s disease (PD). Cerebrospinal fluid (CSF) has been a...

    Wojciech Paslawski, Shervin Khosousi, ... Per Svenningsson in Translational Neurodegeneration
    Article Open access 04 September 2023
  20. An Understanding of Different Mechanisms Leading to Neurodegenerative Diseases

    The prevalence of neurodegenerative disorders is rapidly increasing causing high morbidity and cognitive deterioration in the elder population....
    Diana G. Sami, Mohamed Salama in Handbook of Neurodegenerative Disorders
    Living reference work entry 2023
Did you find what you were looking for? Share feedback.